COSCIENS Biopharma Inc. (CSCI) — Cash Flow Reinvestment Rate
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow Reinvestment Rate of 0.52x as of September 2023, reinvesting $75.15K (capex $8.92K plus investments $-66.24K) from operating cash flow of $144.00K. Explore reinvestment intensity of COSCIENS Biopharma Inc. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Cash Flow Reinvestment Rate (2003–2022)
Historical reinvestment intensity for COSCIENS Biopharma Inc. across 13 annual periods. Also explore CSCI total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year capital reinvestment analysis for COSCIENS Biopharma Inc.. For live market cap and broader valuation context, see CSCI company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $399.39K | $5.23 Million | $10.57K | ▼ -84.4% |
| 2021 | 0.49x | $1.35 Million | $2.75 Million | $555.99K | ▲ +76.2% |
| 2020 | 0.28x | $969.60K | $3.49 Million | $485.46K | ▲ +5372320.5% |
| 2019 | 0.00x | $3.49 | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $3.20 Million | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.71 Million | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $3.03 Million | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $3.98 Million | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $2.16 Million | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $123.30K | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $85.01K | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $66.73K | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $103.05K | $54.42K | $103.05K | — |